Research Article
Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies
Table 5
Cost of CSAI for one patient.
| | Year | 2016 | 2017 | 2018 |
| | Average annual cost | €34,388 | €31,536 | €36,431 | | Apomorphine average annual cost | €25,191 | €22,459 | €27,619 | | % of total cost related to apomorphine | 73% | 71% | 76% |
|
|
